Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients.

MLA

Pignatti, Patrizia, et al. “Hypersensitivity Reactions to Anti-SARS-CoV-2 Vaccines: Basophil Reactivity to Excipients.” Vaccine, vol. 41, no. 32, July 2023, pp. 4693–99. EBSCOhost, https://doi.org/10.1016/j.vaccine.2023.06.039.

APA

Pignatti, P., Ramirez, G. A., Russo, M., Marraccini, P., Nannipieri, S., Asperti, C., Torre, F. D., Tiri, A., Gatti, B. M., Gurrado, A., Meriggi, A., Benanti, G., Cilona, M. B., Pigatto, P., Burastero, S. E., Dagna, L., & Yacoub, M.-R. (2023). Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients. Vaccine, 41(32), 4693–4699. https://doi.org/10.1016/j.vaccine.2023.06.039

Chicago

Pignatti, Patrizia, Giuseppe Alvise Ramirez, Marco Russo, Paolo Marraccini, Serena Nannipieri, Chiara Asperti, Fabrizio Della Torre, et al. 2023. “Hypersensitivity Reactions to Anti-SARS-CoV-2 Vaccines: Basophil Reactivity to Excipients.” Vaccine 41 (32): 4693–99. doi:10.1016/j.vaccine.2023.06.039.